Showing results (311-320 of 335) with videos related to

Sort By:
Pageof 34
Blood|September 30, 2006
Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemiaNeil E Kay, Susan M Geyer, Timothy G Call, et al.
Leukemia|March 26, 2004
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myelomaL F Porrata, M A Gertz, S M Geyer, et al.
Cancer|March 1, 2014
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survivalJonathon B Cohen, Susan M Geyer, Gerard Lozanski, et al.
Blood Advances|April 10, 2024
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancerSteven E Schild, James A Bonner, Thomas G Shanahan, et al.
Leukemia & Lymphoma|July 9, 2025
Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201Charalambos Andreadis, Olivia Bobek, Eric D Hsi, et al.
Molecular Psychiatry|May 16, 2012
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk predictionM Ayalew, H Le-Niculescu, D F Levey, et al.
Leukemia Research|July 31, 2007
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemiaRebekah L Browning, Susan M Geyer, Amy J Johnson, et al.
Blood|November 15, 2008
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximabFarrukh T Awan, Neil E Kay, Melanie E Davis, et al.
Leukemia & Lymphoma|November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulinJeremy T Larsen, William J Hogan, Ivana N Micallef, et al.
Pageof 34